Triple negative (MDA-MB-231) and luminal (MCF7) BC cell lines were cultivated with putative REDD1 inhibitors Apigenin, Resveratrol, Curcumin, Emetin, CGP60474, Rapamycin, Wortmannin, LY294002 individually and in combination with glucocorticoid Dexamethasone. The gene discussed is DDIT4; the disease is breast cancer.